Trials / Recruiting
RecruitingNCT06003660
Brain Neuronal Networks, Chemosensory and Trigeminal Functions in Allo-HSCT
BrainFlavor: Brain Neuronal Networks and Chemosensory and Trigeminal Functions in Allogeneic Hematopoietic Stem Cell Transplantation - a Prospective Cohort-study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (estimated)
- Sponsor
- University of Oslo · Academic / Other
- Sex
- All
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The goal of this prospective, cohort study is to learn about smell, taste and trigeminal dysfunction in patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT). The research team hypothesizes that treatment with allo-HSCT will induce: * Distortion of taste and smell and trigeminal functions like cooling, tingling, and burning sensations. * Reduced saliva production leading to oral dryness and dental caries. * Changes in the connectivity of the taste-, smell- and pain-cortical brain regions.
Detailed description
Participants will undergo various tests: * Smell function assessment with Sniffin' Sticks. * Taste function assessment with Taste Strips. * Oral trigeminal function assessment with von Frey filaments . * Salivary assessment with the Summated Xerostomia Inventory-Dutch questionnaire. * Salivary flow will be measured using salivary flow rate - stimulated whole saliva (SWS). * A clinical oral examination will be done to obtain a Clinical Oral Dryness Score. * Qualitative smell, taste and trigeminal dysfunction will be assessed using a questionnaire. * Radiological and clinical examinations will be performed to evaluate dental and oral mucosal status. * Quality of life using questionnaire. * Nutritional status using questionnaire. * Magnetic resonance imaging of the brain will be taken to capture regions-of-interest for the three different networks of interest; (i) the gustatory network reflecting changes in taste perception, (ii) the olfactory network, related to the changes in smell, and (iii) the pain matrix reflecting pain. There will be a comparisons between the patients and healthy controls.
Conditions
Timeline
- Start date
- 2023-08-10
- Primary completion
- 2025-12-30
- Completion
- 2026-06-30
- First posted
- 2023-08-22
- Last updated
- 2025-03-26
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT06003660. Inclusion in this directory is not an endorsement.